Augmedix (AUGX)
(Real Time Quote from BATS)
$0.92 USD
0.00 (0.21%)
Updated Jun 3, 2024 10:56 AM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AUGX 0.92 0.00(0.21%)
Will AUGX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AUGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AUGX
Health Catalyst (HCAT) Q1 Earnings Beat Estimates
How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%
AUGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
Privia Health (PRVA) Q3 Earnings Miss Estimates
Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?
Other News for AUGX
Predictive Oncology, Augmedix, Cue Health among healthcare movers
Salesforce, Nutanix, Bruker among premarket losers' pack
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
Augmedix appoints Stinard as Chief Clinical AI Officer
Wall Street Breakfast: The Week Ahead